Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07158112 · ClinicalTrials.gov registry record · Phase 4
Assessing Gingivitis and Plaque From a Marketed Toothpaste
A Phase 4 study of Gingivitis, sponsored by Procter and Gamble.
- Active
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07158112: Active Phase 4 study of Gingivitis, sponsored by Procter and Gamble.
NCT07158112 is a Phase 4 study of Gingivitis that is active but no longer recruiting, run by Procter and Gamble. The registered enrollment target is 120 participants, below the 232-participant average among 25 other Gingivitis trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07158112, a Phase 4 study of Gingivitis, is active but no longer recruiting, sponsored by Procter and Gamble.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to evaluate the effect of two 0.454% stannous fluoride dentifrices on gingivitis relative to a negative control (Colgate® Cavity Protection toothpaste) and the comparative anti-gingivitis efficacy of the two 0.454% SnF2 dentifrices after 12 weeks of product use.
Primary Outcome
Number of Bleeding Sites
Conditions Studied
Interventions
- DRUG Stannous Fluoride Dentifrice
- DRUG Test Stannous Fluoride Dentifrice
- DRUG Sodium monofluorophosphate dentifrice
Study Locations (1)
California
- University Health Resources Group - Whitter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-08-30 |
| Est. Completion | 2025-12-07 |
| Phase | Phase 4 |
What the registry record for NCT07158112 still lists
NCT07158112 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 232-participant average among 25 other Gingivitis trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Gingivitis appearing as the primary indexed condition, and to 3 interventions - of which Stannous Fluoride Dentifrice is the first listed.
NCT07158112 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07158112 about?
NCT07158112 is a clinical study titled "Assessing Gingivitis and Plaque From a Marketed Toothpaste". The primary objective of this study is to evaluate the effect of two 0.454% stannous fluoride dentifrices on gingivitis relative to a negative control (Colgate® Cavity Protection toothpaste) and the comparative anti-gingivitis efficacy of the two 0.454% SnF2 dentifrices after 12 weeks of product use...
What is the current status of trial NCT07158112?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2025-08-30. Estimated completion is 2025-12-07.
What conditions does trial NCT07158112 study?
This clinical trial studies the following conditions: Gingivitis.
What interventions are being tested in trial NCT07158112?
The interventions under investigation include: Stannous Fluoride Dentifrice (DRUG), Test Stannous Fluoride Dentifrice (DRUG), Sodium monofluorophosphate dentifrice (DRUG).
Who is sponsoring clinical trial NCT07158112?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07158112 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingivitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07158112's enrollment target sits among peer trials
120 12th of 25 higher than 14 of 25 other Gingivitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gingivitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods
COMPLETED · Phase 4
-
Clinical Investigation of a Toothpaste Containing Stannous Fluoride as Compared to Colgate Fluoride Toothpaste
COMPLETED · Phase 4
-
Imaging-based Assessment of Oral Biofilm and Gingival Health
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
A Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation
RECRUITING · NA
-
Effectiveness of Dual Light Electric Toothbrush vs. Manual Toothbrush in Orthodontic Patients Undergoing Oral Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI